Holen Sie sich die Stockscreener-App
0.5106
9.58%
0.0477
Schlusskurs vom Vortag:
$0.4629
Offen:
$0.49
24-Stunden-Volumen:
7.54M
Relative Volume:
0.26
Marktkapitalisierung:
$30.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.26M
KGV:
-0.4322
EPS:
-1.1814
Netto-Cashflow:
$-13.50M
1W Leistung:
+27.03%
1M Leistung:
-11.01%
6M Leistung:
+13.10%
1J Leistung:
-79.71%
1-Tages-Spanne:
$0.48
$0.53
1-Wochen-Bereich:
$0.351
$0.53
52-Wochen-Spanne:
$0.1853
$3.1663
Intensity Therapeutics Inc Stock (INTS) Company Profile
Firmenname
Intensity Therapeutics Inc
Sektor
Branche
Telefon
203-221-7381
Adresse
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Vergleichen Sie INTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.511 | 27.65M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.26 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
720.06 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.06 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
903.07 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.88 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Intensity Therapeutics Inc Aktie (INTS) Neueste Nachrichten
Intensity Therapeutics stock rises after securing Nasdaq listing extension - Investing.com
Intensity Therapeutics stock rises after securing Nasdaq listing extension By Investing.com - Investing.com India
Intensity Therapeutics Gets Extension to Regain Nasdaq Minimum Price Requirement - marketscreener.com
Intensity Therapeutics Granted Nasdaq Compliance Extension - TipRanks
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule - Investing.com
Intensity Therapeutics granted 180-day extension - marketscreener.com
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule By Investing.com - Investing.com South Africa
Intensity Therapeutics jumps after Nasdaq grants compliance extension - TradingView
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement - PR Newswire
Intensity Therapeutics expands at-the-market offering - MSN
Intensity Therapeutics files for offering of up to $30 million common stockSEC filing - MarketScreener
Intensity Therapeutics expands at-the-market offering program to $30 million - Investing.com Nigeria
Intensity Therapeutics announces two presentations at the upcoming 2025 San Antonio Breast Cancer Symposium - marketscreener.com
Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium - PR Newswire
Intensity Therapeutics expands at-the-market offering program to $30 million By Investing.com - Investing.com South Africa
Intensity Therapeutics Expands At-The-Market Offering - TipRanks
Intensity Therapeutics Expands ATM Offering to $30 Million - TradingView
Aug Shorts: Can Intensity Therapeutics Inc stock resist market sell offs - BỘ NỘI VỤ
How Intensity Therapeutics Inc. stock benefits from global expansionEarnings Recap Report & Verified Chart Pattern Signals - Newser
Delving into the physics of cancer, with Lew Bender - pharmaphorum
Intensity Therapeutics (INTS) Stock Analysis Report | Financials & Insights - Benzinga
The time has not yet come to remove your chips from the table: Intensity Therapeutics Inc (INTS) - Setenews
Intensity Therapeutics shares plunge 30% after $4 million discounted stock offering - MSN
What analysts say about Intensity Therapeutics Inc stockSwing Trading Watchlist & Free Turn Volatility To Profit - earlytimes.in
Can Intensity Therapeutics Inc. stock resist sector downturnsJuly 2025 Rallies & Weekly High Momentum Picks - moha.gov.vn
Why Intensity Therapeutics Inc. stock appeals to analystsQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - moha.gov.vn
Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update (PR Newswire) - Aktiellt
Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - Aktiellt
Trading Recap: Will Intensity Therapeutics Inc. stock split attract more investorsJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - BỘ NỘI VỤ
MSN Money - MSN
Intensity Therapeutics Inc (INTS) looking to reclaim success with recent performance - Setenews
How Intensity Therapeutics Inc. stock reacts to oil prices2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
Will Intensity Therapeutics Inc. stock benefit from AI adoptionMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
How to integrate Intensity Therapeutics Inc. into portfolio analysis tools2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Is Intensity Therapeutics Inc. stock oversold or undervaluedJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
Will a bounce in Intensity Therapeutics Inc. offer an exitQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
Will Intensity Therapeutics Inc. stock reach all time highs in 2025July 2025 Sector Moves & Low Risk High Win Rate Stock Picks - newser.com
How supply chain issues affect Intensity Therapeutics Inc. stock2025 Technical Patterns & Technical Confirmation Alerts - newser.com
Will Intensity Therapeutics Inc. rebound enough to break evenJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - newser.com
Stocks of Intensity Therapeutics Inc (INTS) are poised to climb above their peers - Setenews
Intensity Therapeutics, Inc. (INTS) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How to track smart money flows in Intensity Therapeutics Inc.Swing Trade & Safe Swing Trade Setups - newser.com
Using Bollinger Bands to evaluate Intensity Therapeutics Inc.Bond Market & Weekly Return Optimization Alerts - newser.com
Analysts Offer Insights on Healthcare Companies: Vicarious Surgical (RBOT) and Intensity Therapeutics, Inc. (INTS) - The Globe and Mail
Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):